Success Metrics

Clinical Success Rate

66.7%

Based on 4 completed trials

Completion Rate

67%(4/6)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Terminated

2(22%)

Phase Distribution

Ph phase_4

44%

Ph phase_3

22%

Ph not_applicable

11%

Ph phase_1

11%

Ph phase_2

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 3Large-scale testing

2(22.2%)

Phase 4Post-market surveillance

4(44.4%)

N/ANon-phased studies

1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Terminated(2)

Other(1)

Detailed Status

Completed4

Not yet recruiting2

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (11.1%)

Phase 21 (11.1%)

Phase 32 (22.2%)

Phase 44 (44.4%)

N/A1 (11.1%)

Trials by Status

not_yet_recruiting222%

completed444%

terminated222%

unknown111%

Recent Activity

0 active trials

Showing 5 of 9

not_yet_recruitingphase_3

Morphine or Ketamine for Analgesia

NCT06835504

not_yet_recruitingphase_4

A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough

NCT07288528

terminatedphase_3

Morphine in Moderate Obstructive Sleep Apnoea

NCT03127800

completedphase_4

An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.

NCT02660229

completedphase_4

Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children

NCT03682211

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT06835504Phase 3

Morphine or Ketamine for Analgesia

Not Yet Recruiting

NCT07288528Phase 4

A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough

Not Yet Recruiting

NCT03127800Phase 3

Morphine in Moderate Obstructive Sleep Apnoea

Terminated

NCT02660229Phase 4

An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.

Completed

NCT03682211Phase 4

Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children

Completed

NCT00802308Phase 1

Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers

Completed

NCT00446069Phase 2

A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

Completed

NCT00553553Not Applicable

Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery

Unknown

NCT00270322Phase 4

Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine

Terminated

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9